OHMX.bio is presenting at Life-on-chip event

OHMX.bio’s Chief Scientific Officer and Co-founder, Gerben Menschaert recently took the stage at the prestigious Life-on-Chip event, delivering a compelling presentation on the critical role of sequencing in the future of digital diagnostics and therapeutics. During the talk, the CSO highlighted how advanced sequencing technologies are revolutionizing the way we approach personalized medicine, enabling more accurate diagnostics and more effective therapeutic strategies. By focusing on the integration of sequencing into digital health solutions, the presentation underscored OHMX.bio’s leadership in driving innovation at the intersection of biotechnology and healthcare. This insightful discussion showcased the company’s dedication to leveraging cutting-edge technologies to improve patient outcomes and shape the future of digital diagnostics.